Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ClearLight Diagnostics

ClearLight Diagnostics?uq=w9if130k
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.77M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of a next generation tissue processing and imaging technology aimed at revolutionizing cancer treatment. The company's technology provides a suite of powerful tools, with deep 3-D imaging, which will enable the measurement of important spatial relationships between different cell types, vasculature and nucleic acids within the tumor and surrounding tissue, providing high-resolution information from solid tumors, while maintaining the global perspective needed to understand the complex tumor microenvironment, thereby enabling better treatment decisions for patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • 428 Oakmead Parkway
  • Sunnyvale, CA 94085
  • United States

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ClearLight Diagnostics’s full profile, request a free trial.

ClearLight Diagnostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 08-May-2018 $2.77M 000.00 Completed Product Development
3. Later Stage VC (Series C) 0000 000.00 Completed Startup
2. Early Stage VC (Series B) 03-Oct-2016 $3.5M $6.08M Completed Startup
1. Early Stage VC (Series A) 08-Oct-2015 $2.58M $2.58M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ClearLight Diagnostics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CS Investors Corporation Minority 000 0000 000000 0
Pivotal Paramount Investment Other Minority 000 0000 000000 0
Stanford University Venture Fund Other Minority 000 0000 000000 0
Wiegers Capital Management Growth/Expansion Minority 000 0000 000000 0

ClearLight Diagnostics Executive Team (4)

Name Title Board
Seat
Contact
Info
Laurie Goodman Ph.D Chief Scientific Officer, Interim Chief Executive Officer & Board Manager
Maria Hurst Director of Operations
Karl Deisseroth MD Founder

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

ClearLight Diagnostics Board Members (5)

Name Representing Role Since Contact
Info
Albert Hansen Self Vice Chairman of the Board 000 0000
Alexander Wiegers Wiegers Capital Management Chairman 000 0000
John Snyder Self Board Member 000 0000
Laurie Goodman Ph.D ClearLight Diagnostics Chief Scientific Officer, Interim Chief Executive Officer & Board Manager 000 0000

1 Former Board Member

You’re viewing 4 of 5 board members. Get the full list »